Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04878029 |
|---|---|
| Brief Title: | Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer |
| First Submitted : | April 30, 2021 |
| First Submitted that Met QC Criteria : | May 6, 2021 |
| First Posted : | May 7, 2021 |
| Last Update Submitted that Met QC Criteria : | August 8, 2022 |
| Last Update Posted : | August 10, 2022 |